Kentaro Suzuki's most recent trade in Nautilus Biotechnology Inc was a trade of 160,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus biotech Inc | Kentaro Suzuki | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Kentaro Suzuki | Chief Marketing Officer | Purchase of securities on an exchange or from another person at price $ 1.49 per share. | 06 Nov 2025 | 4,000 | 4,000 | - | 1.5 | 5,960 | Common Stock |
| Nautilus biotech Inc | Kentaro Suzuki | Chief Marketing Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus biotech Inc | Kentaro Suzuki | Chief Marketing Officer | 16 Sep 2024 | 375,000 | 375,000 | - | - | Stock Option (Right to Buy) |